mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.17 |
0.008 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.008 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |